G · Genpact Limited · Stock research

Refresh of coverage first published 2026-07-30; last updated 2026-08-12. Levels here are anchored to the last completed daily close reviewed, $37.14 on 2026-08-21.

G — Genpact Limited

Current Thesis

The leg on offer is unchanged in shape: a headcount-priced services company being repriced as a seller of the software that was supposed to displace it. What has changed since the last update is the tape and the positioning around it. Price closed $37.14 on 2026-08-21 against the $34.29 close of 2026-08-07 that the previous note was anchored to — an 8.3% recovery in two weeks, and 29.1% above the 2026-06-18 fifty-two-week low of $28.77. Sell-side marks followed the Q2 release rather than led it: per stockanalysis.com's compiled ratings table, Baird moved its target from $38 to $45 on 2026-08-07, Citi from $32 to $36 on 2026-08-10, with J.P. Morgan at a $45 Hold and Mizuho at a $39 Hold on 2026-08-11; the compiled average across 12 analysts is $42.18, with a $31 low and a $58 high. The operating pivot is still compounding in the segment data, the multiple has moved only part of the way, and the next event that can settle the argument is roughly eleven weeks out.

The narrative is maturing. The story is well known and still working — twelve covering analysts, targets marked up in the week of 2026-08-07, price up 17.1% over three months — but the headline flow has thinned to nothing since the 2026-08-12 update, and the stock remains 22.6% below the $47.99 fifty-two-week high. New attention is not arriving; the existing bid is doing the work.

Bullish and bearish views on Genpact Limited

The model's bull view on Genpact Limited (G), in brief: Advanced Technology Solutions revenue $363M in Q2 2026, +24.1% YoY and 27% of net revenue, with full-year ATS growth guidance lifted to at least 25% on the 2026-08-06 call. The bear view: At the consolidated line the Q2 raise was inside the rounding: FY2026 adjusted EPS guided above $4.09 against $4.07 consensus, revenue above $5.436B against $5.435B. Both cases follow in full.

Bull Case

• Advanced Technology Solutions revenue $363M in Q2 2026, +24.1% YoY and 27% of net revenue, with full-year ATS growth guidance lifted to at least 25% on the 2026-08-06 call.
• Agentic solutions tracking to over $1B of total contract value booked in 2026, described on that call as roughly five times 2025; agentic work was near 40% of Q2 bookings, and 12 large deals were signed year-to-date against 6 a year earlier.
• Non-FTE revenue crossed 50% of total for the first time (Q2 call, 2026-08-06), which is the structural rebuttal to the claim that agents deflate this revenue model.
• Gross margin 36.5% in Q2, the thirteenth consecutive quarter of expansion; adjusted diluted EPS $1.00, +13.6% YoY on 7.1% revenue growth. The Form 10-Q filed 2026-08-07 shows first-half net income of $293.7M against $263.6M a year earlier.
• The issuer is a buyer of its own float: ~1.6M shares repurchased for ~$50M in Q2 plus $32M of dividends, with the quarterly dividend raised to $0.1875 on 2026-07-16.
• The post-print broker marks reset the reference band higher — the 2026-08-21 close of $37.14 sits above Citi's raised $36 and below Mizuho's $39, with the compiled 12-analyst average at $42.18.

Bear Case

• At the consolidated line the Q2 raise was inside the rounding: FY2026 adjusted EPS guided above $4.09 against $4.07 consensus, revenue above $5.436B against $5.435B. Q2 revenue of $1.3434B came in under the $1.359B consensus figure.
• Q3 guidance sits at or below consensus on every line — revenue $1.369–1.382B vs $1.382B, adjusted EPS $1.04–1.05 vs $1.05, GAAP EPS $0.89–0.90 vs $0.91.
• Core Business Services grew 1.9% in Q2 to $980M and is guided flat-to-slightly-down for Q3.
• An insider sold into the base rather than the rally: 29,095 shares on 2026-08-11 and 2026-08-12 at ~$33.94 average, roughly 28% of the direct holding, and the filing was not marked as executed under a Rule 10b5-1 plan.
• Cash conversion remains back-half dependent: first-half operating cash flow $48.9M against first-half GAAP net income of $293.7M, with cash of $517.4M and total debt of $1.18B at 2026-06-30.
• Nothing company-specific is scheduled inside the next 30 days, so the name trades on sector flow into a September that contains a peer print it does not control.

Setup & Price Structure

• Reference close $37.14 on 2026-08-21; RSI(14) at 61.3 — advancing, not stretched. The shares are up 17.1% over three months and sit 22.6% under the $47.99 fifty-two-week high.
• The structure since 2026-06-18 is a series of higher lows off $28.77, with the 2026-08-07 post-print close of $34.29 now acting as the shelf beneath the current range. Recovering $34.29 and holding it is what separates a base from a failed bounce.
• Crowding and positioning observables, stated as observed: analyst target changes clustered in the four sessions after the 2026-08-06 release and have been silent since 2026-08-11; the compiled consensus average of $42.18 sits 13.6% above the last close, so price is not yet trading through the street's marks; the Form 4 sale of 29,095 shares on 2026-08-11/12 landed roughly $3 below the current close; and there is no earnings date inside 30 days to force positioning either way.
• Retail-sentiment coverage on this name is thin — the last two syndicated headlines in the 30-day window were both broker-target notes from early July (TD Cowen $42 on 2026-07-09, Baird $38 on 2026-07-07). That absence is consistent with the maturing label rather than an accelerating one.

Catalyst Calendar (next 30 days)

• 2026-09-10 — $0.1875 quarterly dividend goes ex (declared 2026-07-16, payable 2026-09-24). The only hard dated corporate item inside the window; it confirms capital-return continuity and resolves nothing about the growth mix.
• ~2026-09-22 (est.) — end of the 30-day window with no scheduled company disclosure; any move before then is sector flow or a broker action, not new company information.
• ~2026-09-25 (est.) — Accenture fiscal Q4 results and initial FY2027 guidance. Just outside the window, and historically the event that resets services multiples ahead of Genpact's own print.
• ~2026-10-14 (est.) — Indian IT services September-quarter results season; read-through on discretionary enterprise spend and on whether clients are capturing AI productivity gains through price.
• ~2026-11-05 (est.) — Q3 FY26 earnings. The binary for this thesis: whether Core Business Services declines outright as guided, whether ATS holds at or above 25%, and whether the ~2pp portfolio-exit headwind lands as sized on 2026-08-06.

What Would Change Our Mind

The structural break is the loss of the post-print shelf. A weekly close below $34 hands back the entire advance since the 2026-08-06 release, puts price under the 2026-08-07 close of $34.29, and re-opens the range down toward the 2026-06-18 low of $28.77 — at which point the re-rate attempt has failed on the tape regardless of what the segment data says.

Three non-price conditions would do the same work. First, Core Business Services printing an outright YoY revenue decline at the Q3 report (~2026-11-05, est.) while ATS growth decelerates below 20% — that combination removes the arithmetic that makes 7% consolidated growth improve from here. Second, a cut to the "at least 7%" full-year revenue frame, which would mean portfolio exits are larger than the roughly two points management sized on 2026-08-06. Third, the 2026-09-10 dividend date passing with the stock unable to hold above the $34.29 shelf into a quiet October, which would date the narrative as drifting rather than maturing.

On the other side, a Q3 print with ATS above 25% and Core Business Services merely flat, plus nine-month operating cash flow closing most of the gap to the $293.7M of first-half net income, would upgrade this from a story about mix to a story about compounding — and would justify revisiting the LOW conviction attached to a fresh entry at current levels.

Correlation Notes

• Highest-beta linkage is to Accenture's fiscal Q4 guide (~2026-09-25, est.) and to the Indian IT complex (Infosys, Wipro, TCS) reporting from mid-October. A group de-rate can arrive here with no Genpact-specific news.
• Delivery footprint is weighted to India, so INR/USD and Indian tax changes flow directly into reported margin; the ~36.5% full-year gross margin guide is exposed to that channel.
• The name sits on the wrong side of the "AI displaces services labour" trade and the right side of the "agentic software vendor" trade simultaneously. Flows into AI-application software and flows out of headcount-priced outsourcing can hit the same ticker in the same session, which is part of why the multiple has lagged the segment data.
• Bermuda-incorporated and NYSE-listed; index membership is US large/mid-cap services, so passive flow tracks the domestic services complex rather than Indian IT.